{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:25:47Z","timestamp":1791069947103,"version":"4.1.0"},"reference-count":24,"publisher":"American Society of Hematology","issue":"22","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tumor cells in classic Hodgkin lymphoma produce high quantities of the thymus- and activation-related chemokine (TARC). We measured TARC levels in prediagnostic serum samples and found strikingly increased values in the vast majority of patients, as early as 6 years before diagnosis.<\/jats:p>","DOI":"10.1182\/blood.2023020959","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T20:44:27Z","timestamp":1695674667000},"page":"1928-1931","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years"],"prefix":"10.1182","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-1050","authenticated-orcid":false,"given":"Arjan","family":"Diepstra","sequence":"first","affiliation":[{"name":"1Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5047-4077","authenticated-orcid":false,"given":"Ilja M.","family":"Nolte","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-2638","authenticated-orcid":false,"given":"Anke","family":"van den Berg","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-2474","authenticated-orcid":false,"given":"Larry I.","family":"Magpantay","sequence":"additional","affiliation":[{"name":"3Department of Obstetrics and Gynecology, UCLA AIDS Institute and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1364-0675","authenticated-orcid":false,"given":"Otoniel","family":"Mart\u00ednez-Maza","sequence":"additional","affiliation":[{"name":"3Department of Obstetrics and Gynecology, UCLA AIDS Institute and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-6493","authenticated-orcid":false,"given":"Lynn I.","family":"Levin","sequence":"additional","affiliation":[{"name":"4Statistics and Epidemiology Branch, Walter Reed Army Institute of Research, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2023113016210845200_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-030-32482-7_1","volume-title":"Hodgkin Lymphoma: a Comprehensive Overview","author":"Hjalgrim","year":"2020","edition":"3rd ed"},{"issue":"6","key":"2023113016210845200_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0002-9440(10)65424-7","article-title":"High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma","volume":"154","author":"van den Berg","year":"1999","journal-title":"Am J Pathol"},{"issue":"23","key":"2023113016210845200_bib3","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"2023113016210845200_bib4","doi-asserted-by":"crossref","first-page":"2033433","DOI":"10.1080\/2162402X.2022.2033433","article-title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: characterizing CD4+ T cells in Hodgkin lymphoma","volume":"11","author":"Veldman","year":"2022","journal-title":"Oncoimmunology"},{"issue":"21","key":"2023113016210845200_bib5","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood.2020005546","article-title":"Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58","volume":"136","author":"Veldman","year":"2020","journal-title":"Blood"},{"key":"2023113016210845200_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-030-32482-7_4","volume-title":"Hodgkin Lymphoma: a Comprehensive Overview","author":"Visser","year":"2020","edition":"3rd ed"},{"issue":"3","key":"2023113016210845200_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/his.14836","article-title":"The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics","volume":"82","author":"Kilsdonk","year":"2023","journal-title":"Histopathology"},{"issue":"5","key":"2023113016210845200_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2141.2007.06964.x","article-title":"Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22","volume":"140","author":"Niens","year":"2008","journal-title":"Br J Haematol"},{"issue":"5","key":"2023113016210845200_bib9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/bjh.14317","article-title":"Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC","volume":"175","author":"Plattel","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"2023113016210845200_bib10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3324\/haematol.2011.053199","article-title":"Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma","volume":"97","author":"Plattel","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"2023113016210845200_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bjh.16514","article-title":"Interim thymus and activation regulated chemokine versus interim (18) F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation","volume":"190","author":"Plattel","year":"2020","journal-title":"Br J Haematol"},{"issue":"12","key":"2023113016210845200_bib12","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1038\/s41375-022-01717-8","article-title":"Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP","volume":"36","author":"Driessen","year":"2022","journal-title":"Leukemia"},{"issue":"12","key":"2023113016210845200_bib13","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2105\/AJPH.92.12.1900","article-title":"The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance","volume":"92","author":"Rubertone","year":"2002","journal-title":"Am J Public Health"},{"issue":"2","key":"2023113016210845200_bib14","doi-asserted-by":"crossref","first-page":"e0114857","DOI":"10.1371\/journal.pone.0114857","article-title":"Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012","volume":"10","author":"Perdue","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"2023113016210845200_bib15","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/1055-9965.EPI-16-1012","article-title":"Elevated serum levels of sCD30\u00a0and IL6 and detectable IL10 precede classical Hodgkin lymphoma diagnosis","volume":"26","author":"Levin","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"2023113016210845200_bib16","doi-asserted-by":"crossref","first-page":"e029228","DOI":"10.1136\/bmjopen-2019-029228","article-title":"Socioeconomic deprivation and regional variation in Hodgkin's lymphoma incidence in the UK: a population-based cohort study of 10 million individuals","volume":"9","author":"Rafiq","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"2023113016210845200_bib17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"2023113016210845200_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jnci\/djr516","article-title":"Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups","volume":"104","author":"Urayama","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"2023113016210845200_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.critrevonc.2012.07.002","article-title":"Hodgkin lymphoma","volume":"85","author":"Gobbi","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"18","key":"2023113016210845200_bib20","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood-2017-09-808907","article-title":"Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation","volume":"131","author":"Vigano","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2023113016210845200_bib21","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","article-title":"Biomarkers in atopic dermatitis\u2014a review on behalf of the International Eczema Council","volume":"147","author":"Renert-Yuval","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"2023113016210845200_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-021-00857-w","article-title":"What does elevated TARC\/CCL17 expression tell us about eosinophilic disorders?","volume":"43","author":"Catherine","year":"2021","journal-title":"Semin Immunopathol"},{"issue":"17","key":"2023113016210845200_bib23","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1182\/blood-2015-04-639781","article-title":"Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: a joint study from five Nordic countries","volume":"126","author":"Kharazmi","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2023113016210845200_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/bjh.15622","article-title":"Current treatment paradigms for advanced stage Hodgkin lymphoma","volume":"184","author":"Longley","year":"2019","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/22\/1928\/2091063\/blood_bld-2023-020959-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/22\/1928\/2091063\/blood_bld-2023-020959-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T16:21:26Z","timestamp":1701361286000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/22\/1928\/498057\/Elevated-serum-TARC-levels-precede-classic-Hodgkin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":24,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,11,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023020959","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}